Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The benefit of self-monitoring of blood glucose in reducing HbA1c in non-insulin-treated participants remains unclear. HbA1c may be improved in this population with said self-monitoring. OBJECTIVE: The aim of this study was to conduct meta-analyses of glycemic control in non-insulin-treated participants with Type 2 diabetes: self-monitoring of blood glucose versus usual care, structured versus unstructured self-monitoring of blood glucose, and use of self-monitoring of blood glucose readings by clinicians to adjust (or modify) therapy versus usual care. METHODS: MEDLINE, Embase, and Cochrane Central were electronically searched to identify articles published from January 1, 2000, to June 30, 2020. Trials investigating changes in HbA1c were selected. Screening was performed independently by two investigators. Two investigators extracted HbA1c at baseline and follow-up for each trial. RESULTS: Nineteen trials involving 4,965 participants were included. Overall, self-monitoring of blood glucose reduced HbA1c. Preplanned subgroup analysis showed that using self-monitoring of blood glucose readings to adjust therapy contributed significantly to the reduction. No significant improvement in HbA1c was shown in self-monitoring of blood glucose without therapy adjustment. The same difference was observed in structured versus unstructured self-monitoring of blood glucose. DISCUSSION: HbA1c is improved with clinician therapy modification based on structured self-monitoring of blood glucose readings. Implications are for clinicians to prescribe structured self-monitoring of blood glucose to modify therapy based on the readings and not prescribe unstructured self-monitoring of blood glucose. Participants with suboptimal glycemic control may benefit most. A self-monitoring of blood glucose regimen that improves clinical and cost-effectiveness is presented. Future studies can investigate this regimen specifically.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter is consistent with the findings of two prior meta-analyses, which identified greater clinical benefit when SMBG was followed by responsive treatment modifications (29, 30).”
In the citing paper
“Recent meta-analyses (29, 30) have examined the clinical efficacy of sSMBG compared to uSMBG, among adults with non-insulin-treated type 2 diabetes. They identified greater improvement in HbA1c associated with sSMBG (29, 30)”
In the citing paper
“However, inclusion criteria specified randomized controlled trials (RCTs) including a uSMBG comparator (k=3 (29) and k=4 (30)), thus overlooking evidence where sSMBG was compared to usual care, no SMBG, or CGM.”
In the citing paper
“Such targeted use of sSMBG may be both clinically- and cost-effective (21, 29, 30).”
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 4×
“Publication bias was investigated by asymmetry testing: Funnel plots were examined visually if 10 or more trials were included in the analyses (Egger et al., 1997; Sterne et al., 2011).”
BackgroundMethodInfluentialLuo, D., Wan, X., Liu, J., & Tong, T. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280216669183 · Cited by 4,066 · cited 2×
“If the median was available but not the mean, the latter was transformed from the former (Luo et al., 2018); SD was estimated from the interquartile range when only this was obtainable (Wan et al., 2014).”
BackgroundDavies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 10×
“The ADA, EASD, and IDF recommend prescribing SMBG with therapy adjustment, though this is based on expert consensus and not empirical evidence (Davies et al., 2018; IDF, 2018); the IDF calls for further evidence (IDF, 2018).”
BackgroundMethodInfluentialU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Cited by
Zou, Y. L., Zhao, S., Li, G., & Zhang, C. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07864-z · Cited by 27
Jackson, S. L., Woodruff, R. C., Nagavedu, K., Fearrington, J., Rolka, D. B., Twentyman, E., Carton, T. W., Puro, J. E., Denson, J. L., Kappelman, M. D., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.030240 · Cited by 27
Jackson, S. L., Lekiachvili, A., Block, J. P., Richards, T. B., Nagavedu, K., Draper, C., Koyama, A. K., Womack, L. S., Carton, T. W., Mayer, K. H., et al. (2024) · Preventing Chronic Disease · doi:10.5888/pcd21.230415 · Cited by 21
Li, Y., Zhong, Q., Zhu, S., Cheng, H., Huang, W., Wang, H., & Li, Y.-T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114175 · Cited by 21
Litchfield, I. J., Barrett, T. G., Hamilton-Shield, J. P., Moore, T. H., Narendran, P., Redwood, S., Searle, A., Uday, S., Wheeler, J., & Greenfield, S. (2023) · International Journal for Equity in Health · doi:10.1186/s12939-023-01976-6 · Cited by 19
Metadata
- Authors
- Chircop, J., Sheffield, D., & Kotera, Y.
- Affiliations
- University of Derby (GB)
- Venue
- Nursing Research
- Published
- 2021-07-21
- Volume
- 70
- Issue
- 6
- Pages
- 487-497
- ISSN
- 0029-6562 (ISSN-L)
- 1538-9847
- OpenAlex
- W3186342387
- Cited by
- 34
- References
- 50
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 5 · 2023: 9 · 2022: 4
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nursing Research (publishedVersion)
- PubMed (publishedVersion)
- University of Derby Online Research Archive. (University of Derby) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- self-monitoring of blood glucose, type 2 diabetes, glycemic control, HbA1c, non-insulin-treated patients, usual care, cost-effectiveness
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes. https://app.cochat.ai/papers/10.1097/nnr.0000000000000542
- The paper
- Chircop, J., Sheffield, D., & Kotera, Y. (2021). Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes. Nursing Research. https://doi.org/10.1097/nnr.0000000000000542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.